Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvation Bio, Inc.

2.09
+0.04001.95%
Post-market: 2.100.0100+0.48%16:57 EDT
Volume:3.37M
Turnover:6.98M
Market Cap:711.15M
PE:-1.03
High:2.12
Open:2.05
Low:2.01
Close:2.05
Loading ...

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB)

TIPRANKS
·
02 Apr

BRIEF-Nuvation Bio Enters Supply Agreement With Asymchem For Taletrectinib

Reuters
·
25 Mar

Nuvation Bio Inc - Enters Supply Agreement With Asymchem for Taletrectinib - SEC Filing

THOMSON REUTERS
·
25 Mar

BRIEF-Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025

Reuters
·
25 Mar

Insider Stock Buying Reaches US$720.1k On Nuvation Bio

Simply Wall St.
·
25 Mar

Nuvation Bio to Present Matching-Adjusted Indirect Comparison Data for Taletrectinib VS. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025

THOMSON REUTERS
·
25 Mar

Nuvation Bio Positioned for Growth with Key Therapeutics and Strategic Leadership

TIPRANKS
·
12 Mar

Nuvation Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
10 Mar

Nuvation Bio price target lowered to $10 from $11 at H.C. Wainwright

TIPRANKS
·
10 Mar

Nuvation Bio files automatic mixed securities shelf

TIPRANKS
·
07 Mar

BRIEF-Nuvation Bio Inc Files For Mixed Shelf, Size Not Disclosed

Reuters
·
07 Mar

Nuvation Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

Nuvation Bio Q4 2024 GAAP EPS $(0.15) Misses $(0.14) Estimate

Benzinga
·
07 Mar

Nuvation Bio reports Q4 EPS (15c), two estimates (12c)

TIPRANKS
·
07 Mar

BRIEF-Nuvation Bio Q4 EPS USD -0.15

Reuters
·
07 Mar

Nuvation Bio Q4 Operating Expenses USD 55.437 Million

THOMSON REUTERS
·
07 Mar

Press Release: Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
07 Mar

BRIEF-Nuvation Bio Enters Supply Agreement With Asymchem Laboratories

Reuters
·
06 Mar

Nuvation Bio Inc - Asymchem to Supply Taletrectinib to Nuvation Bio

THOMSON REUTERS
·
06 Mar

Nuvation Bio to Receive Up to $250 Million in Funding From Sagard Healthcare Partners

MT Newswires Live
·
03 Mar